On March 3, 2020, the Innovative Medicines Initiative 2 (IMI2) opened a research and innovation action for the new corona virus (COVID-2019).

Topic

• Development of therapeutics and diagnostics combatting coronavirus infections

Scope: Considering that this is a newly-identified virus, the scope of this topic remains broad and must address at least one of the following objectives:

• development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak;
• development of therapeutics to address the current and/or future coronavirus outbreaks;
• development of diagnostics, ensuring rapid evaluation of candidates based on existing technologies;
• development of fast and reliable tools that go beyond the state of the art for detection of COVID-19 carriers and symptomatic individuals suspected of COVID-19 infection.

Preventive vaccines are specifically excluded from the scope of the Call.

The call budget is approx. 45 million euros. The application deadline is on March 31, 2020.

Offizielle Website: https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-21

Contact at EPC

© TU Dresden

Project Manager / EPC Contact School of MED

Name

Ms Beate Brenner

Horizon Europe (Projects School of MED)

Send email

Send encrypted email via the SecureMail portal (for TUD external users only).

Organization Name

European Project Center

European Project Center

Address work

Visiting address:

FAL Falkenbrunnen BT-A Würzburger Straße 35

01187 Dresden

Show map of this location.

work Tel.